# PONVORY

NDC: 50458-720
Generic name: Ponesimod
Labeler / Manufacturer: Janssen Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210318
Marketing ended: 20270331
FDA application: NDA213498

## Active ingredients

- PONESIMOD: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-720"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-720
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5be69660-738c-4db7-b0d4-517aa873dc41